NattoPharma

Investor Relations

Welcome to NattoPharma's Investor Relations web page. NattoPharma's principal shareholder policy is to maximize returns earned by its shareholders over time and we strive to protect our shareholders' investments.

The aim of our investor relations policy is to make sure that Norwegian and international investors are treated equally. NattoPharma is committed to provide the financial market and other interested parties with correct, consistent and relevant information in order to enhance the understanding of the company. Thus ensuring that the value assessment of NattoPharma's underlying value and future growth prospects is formed on the best possible basis.

NattoPharma ASA was admitted to the Oslo Stock Exchange list "Oslo Axess" as per January 30th 2008. The ticker name is NATTO.

Intervju with NattoPharma CEO Morten Sundstø.
Please click on the link below and you will be redirected to OSIX news webpage. Here you will have to write natto in the search box and the intervju will come up. 

 http://www.osixmedia.com/media.aspx

Latest press releasesUpdated 3:15 AM

  • Interim Report 2 Quarter 2010 NattoPharma ASA

    31 August 2010

    This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act) Highlights     "All time high" revenue in 2nd quarter 2010

  • Korreksjon av emisjon NattoPharma

    31 August 2010

    This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act) Det vises til melding kl 09:01 i dag angående emisjon i NattoPharma ASA. Korrekt antall tegnede aksjer er...

Latest reportsUpdated 3:15 AM

Financial calendar

25 November 2010 2010, Third Quarter Results
31 August 2010 2010, Second Quarter Results
27 May 2010 2010, First Quarter Results
26 February 2010 2009, Fourth Quarter Results
13 November 2009 2009, Third Quarter Results
more events
IR contact
Morten Sundstø
President & CEO
Tel: (+47) 950 61 860
morten@sundsto.com